Paper Details
- Home
- Paper Details
First case of acute cholestatic hepatitis attributed to oseltamivir in a young girl with ah1n1 influenza.
Author: GrecoS, GuadagninoG, MastroianniA, MauroM V, RitaccaR, VangeliV
Original Abstract of the Article :
Oseltamivir caryboxylase is a potent inhibitor of the enzyme neuramidase of the influenza virus particle and it is active against both influenza A and B viruses. Oseltamivir is indicated for therapy or post-exposure prevention of influenza A and B. Side effects are uncommon and include mild nausea, ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.7416/ai.2021.2427
データ提供:米国国立医学図書館(NLM)
A Case for Caution: Oseltamivir and the Development of Acute Cholestatic Hepatitis
Oseltamivir, an antiviral medication used to treat influenza infections, is generally considered safe. However, this case report describes a [rare adverse event associated with oseltamivir: acute cholestatic hepatitis]. The authors present the case of a young girl who developed acute hepatitis after receiving oseltamivir for influenza H1N1 infection. This report emphasizes the need for vigilant monitoring of liver function and a careful assessment of potential drug interactions.A Reminder for Vigilance: Recognizing Potential Adverse Effects of Medications
This case report underscores the importance of [closely monitoring patient's health status] when they are prescribed medications, even those considered to be safe. It highlights the potential for unexpected adverse events, even in seemingly innocuous medications like oseltamivir. Healthcare providers and patients should be aware of the potential risks and benefits of all medications and report any unusual symptoms promptly.Navigating the Health Landscape: The Importance of Open Communication with Healthcare Providers
This case report reminds us that [open communication between patients and healthcare providers] is crucial for ensuring safe and effective treatment. Patients should feel comfortable discussing any concerns or side effects they experience while taking medications. Healthcare providers should also be proactive in monitoring patient health and being aware of potential drug interactions and adverse events.Dr. Camel's Conclusion
Just as a desert traveler may encounter unexpected storms, the journey through illness can sometimes bring unexpected detours. This case report reminds us that even familiar medications can have unforeseen consequences. By being vigilant, open to communication, and proactive in our healthcare decisions, we can navigate the health landscape with greater confidence and ensure a smoother journey towards well-being.Date :
- Date Completed 2021-10-25
- Date Revised 2021-10-25
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.